Transcriptional regulation of plasminogen activator inhibitor-1 expression by insulin-like growth factor-1 via MAP kinases and hypoxia-inducible factor-1 in HepG2 cells

Summary

Insulin-like growth factor 1 (IGF-1) and plasminogen activator inhibitor-1 (PAI-1) appear to play a crucial role in a number of processes associated with growth and tissue remodelling. IGF-1 was shown to enhance PAI-1 expression in primary hepatocytes and HepG2 hepatoma cells, but the molecular mechanisms underlying this effect have not been fully elucidated. In this study, we investigated the transcriptional mechanism and the signaling pathway by which IGF-1 mediates induction of PAI-1 expression in HepG2 cells. By using human PAI-1 promoter reporter gene assays we found that mutation of the hypoxia responsive element (HRE), which could bind hypoxia-inducible factor-1 (HIF-1), nearly abolished the induction by IGF-1. We found that IGF-1-induced up-regulation of PAI-1 expression was associated with activation of HIF-1α. Furthermore, IGF-1 enhanced HIF-1α protein levels and HIF-1 DNA-binding to each HRE, E4 and E5 as shown by EMSA. Mutation of the E-boxes, E4 and E5, did not affect the IGF-1-dependent induction of PAI-1 promoter constructs under normoxia but abolished the effect of IGF-1 under hypoxia. Inhibition of either the PI3K by LY294002 or ERK1/2 by U0126 reduced HIF-1α protein levels while both inhibitors together completely abolished the IGF-1 effect on HIF-1α. Remarkably, transfection of HepG2 cells with vectors expressing a dominant-negative PDK1 or the PKB inhibitor, TRB3, did not influence while dominant-negative Raf inhibited the IGF-1 effect on HIF-1α. Thus, IGF-1 activates human PAI-1 gene expression through activation of the PI3-kinase and ERK1/2 via HIF-1α.

Keywords

Plasminogen activator inhibitor-1 - insulin-like growth factor - hypoxia-inducible factor-1 - phosphatidylinositol-dependent kinase-1 - extracellular regulated kinase

• References

• 1 Lijnen HR, Collen D. Mechanisms of plasminogen activation by mammalian plasminogen activators. Enzyme 1988; 40: 90-6
• 2 Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. New Engl J Med 2000; 342: 1792-801
• 3 Erickson LA, Hekman CM, Loskutoff DJ. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc Natl Acad Sci U S A 1985; 82: 8710-4
• 4 Reilly CF, McFall RC. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem 1991; 266: 9419-27
• 5 Heaton JH, Nebes VL, O'Dell LG. et al Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol 1989; 3: 185-92
• 6 Busso N, Nicodeme E, Chesne C. et al Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 1994; 20: 186-90
• 7 Eddy AA. Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 2002; 283: F209-F220
• 8 Blakesley VA, Scrimgeour A, Esposito D. et al Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?. Cytokine Growth Factor Rev 1996; 7: 153-9
• 9 Furstenberger G, Morant R, Senn HJ. Insulin-like growth factors and breast cancer. Onkologie 2003; 26: 290-4
• 10 Damante G, Cox F, Rapoport B. IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter. Biochem Biophys Res Commun 1988; 151: 1194-9
• 11 Alemany J, Borras T, de Pablo F. Transcriptional stimulation of the delta 1-crystallin gene by insulin-like growth factor I and insulin requires DNA cis elements in chicken. Proc Natl Acad Sci U S A 1990; 87: 3353-7
• 12 Thiebaud D, Ng KW, Findlay DM. et al Insulin-like growth factor 1 regulates mRNA levels of osteonectin and pro-alpha 1(I)-collagen in clonal preosteoblastic calvarial cells. J Bone Miner Res 1990; 5: 761-7
• 13 Goad DL, Rubin J, Wang H. et al Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 1996; 137: 2262-8
• 14 Warren RS, Yuan H, Matli MR. et al Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem 1996; 271: 29483-8
• 15 Gustafsson H, Tamm C, Forsby A. Signalling pathways for insulin-like growth factor type 1-mediated e pression of uncoupling protein 3. J Neurochem 2004; 88: 462-8
• 16 Anfosso F, Alessi MC, Nalbone G. et al Up-regulated expression of plasminogen activator inhibitor-1 in Hep G2 cells: interrelationship between insulin and insulin- like growth factor 1. Thromb Haemost 1995; 73: 268-74
• 17 Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states [published erratum appears in Proc Natl Acad Sci U S A 1992 ;89:1148]. Proc Natl Acad Sci U S A 1991; 88: 9959-63
• 18 Padayatty SJ, Orme S, Zenobi PD. et al The effects of insulin-like growth factor-1 on plasminogen activator inhibitor-1 synthesis and secretion: results from in vitro and in vivo studies. Thromb Haemost 1993; 70: 1009-13
• 19 Kietzmann T, Samoylenko A, Roth U. et al Hypoxia- inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor- 1 gene expression by insulin in primary rat hepatocytes. Blood 2003; 101: 907-14
• 20 Fattal PG, Schneider DJ, Sobel BE. et al Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulinlike growth factor 1. J Biol Chem 1992; 267: 12412-5
• 21 Fink T, Kazlauskas A, Poellinger L. et al Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor- 1. Blood 2002; 99: 2077-83
• 22 Currie RA, Walker KS, Gray A. et al Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem J 1999; 337: 575-83
• 23 Du K, Herzig S, Kulkarni RN. et al TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003; 300: 1574-7
• 24 Dent P, Reardon DB, Morrison DK. et al Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Rasindependent mechanisms in vitro. Mol Cell Biol 1995; 15: 4125-35
• 25 Immenschuh S, Hinke V, Ohlmann A et al.. Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein- 1 element in primary cultures of rat hepatocytes. Biochem J 1998; 334: 141-6
• 26 Kietzmann T, Roth U, Freimann S. et al Arterial oxygen partial pressures reduce the insulin-dependent induction of the perivenously located glucokinase in rat hepatocyte cultures: mimicry of arterial oxygen pressures by H2O2. Biochem J 1997; 321: 17-20
• 27 Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia inducible factor-1 in rat hepatocytes. Blood 1999; 94: 4177-85
• 28 Kietzmann T, Cornesse Y, Brechtel K. et al Perivenous expression of the mRNA of the three hypoxia-in ducible factor alpha-subunits, HIF1alpha, HIF2alpha and HIF3alpha, in rat liver. Biochem J 2001; 354: 531-7
• 29 Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-89
• 30 Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-54
• 31 Zelzer E, Levy Y, Kahana C. et al Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 1998; 17: 5085-94
• 32 Kietzmann T, Jungermann K, Gorlach A. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases in HepG2 cells. Thromb Haemost 2003; 89: 666-74
• 33 Alessi MC, Juhan VI, Kooistra T. et al Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line HepG2. Thromb Haemost 1988; 60: 491-4
• 34 Kooistra T, Bosma PJ, Tons HA. et al Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 1989; 62: 723-8
• 35 Banfi C, Eriksson P, Giandomenico G. et al Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. Diabetes 2001; 50: 1522-30
• 36 Vulin AI, Stanley FM. A Forkhead/winged helixrelated transcription factor mediates insulin-increased plasminogen activator inhibitor-1 gene transcription. J Biol Chem 2002; 277: 20169-76
• 37 Feldser D, Agani F, Iyer NV. et al Reciprocal positive regulation of hypoxia-inducible factor 1 alpha and insulin-like growth factor 2. Cancer Res 1999; 59: 3915-8
• 38 Fukuda R, Hirota K, Fan F. et al Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002; 277: 38205-11
• 39 Burroughs KD, Oh J, Barrett JC. et al Phosphatidylinositol 3-kinase and MEK1/2 are necessary for insulin- like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1?. Mol Cancer Res 2003; 1: 312-22
• 40 Sandau KB, Faus HG, Brune B. Induction of hypoxia- inducible-factor 1 by nitric oxide is mediated via the PI3K pathway. Biochem Biophys Res Commun 2000; 278: 263-7
• 41 Gorlach A, Diebold I, Schini-Kerth VB. et al Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 2001; 89: 47-54
• 42 Laughner E, Taghavi P, Chiles K. et al HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995-4004
• 43 Treins C, Giorgetti-Peraldi S, Murdaca J. et al Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 2002; 277: 27975-81
• 44 Zundel W, Schindler C, Haas KD. et al Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391-6
• 45 Sodhi A, Montaner S, Miyazaki H. et al MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem Biophys Res Commun 2001; 287: 292-300
• 46 Alvarez-Tejado M, Alfranca A, Aragones J. et al Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia- inducible factors by low oxygen tension. J Biol Chem 2002; 277: 13508-17.
• 47 Hirota K, Fukuda R, Takabuchi S. et al Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling. J Biol Chem 2004; 279: 41521-8
• 48 Zhong H, Simons JW. Activation of hypoxia-inducible factor 1 alpha by oxygen independent pathways. Exp Oncol 2001; 23: 88-96
• 49 Schmidt EK, Fichelson S, Feller SM. PI3 kinase is important for Ras, MEK and Erk activation of Epostimulated human erythroid progenitors. BMC Biol 2004; 2: 7
• 50 Muscella A, Greco S, Elia MG. et al PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells. J Cell Physiol 2003; 197: 61-8